Association Between Irisin, Inflammatory Markers and Metabolic Status in Obese Children With Type 2 Diabetes Mellitus

NCT03767608 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2018-12-06

No results posted yet for this study

Summary

The objective of this study was to investigate the association of irisin with inflammatory markers as well with metabolic and anthropometric parameters in children and adolescents with type 2 diabetes mellitus compared with healthy controls.

Conditions

  • Diabetes Mellitus, Type 2
  • Pediatric Obesity

Sponsors & Collaborators

  • Instituto Tecnologico y de Estudios Superiores de Monterey

    lead OTHER

Principal Investigators

  • Leticia Elizondo-Montemayor, MD · Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-01-01
Completion
2017-01-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03767608 on ClinicalTrials.gov